Table 5.

Factors^* at admission period associated with pharmacologic pain management during the 90-day observation period among newly admitted nursing home residents with cancer (N=3,268).

Characteristic	Pharmacologic intensification (%)	Crude	Adjusted¶
		Odds ratio (95% Confidence Interval)
Age, years
65–74	27.3	Reference	Reference
75–84	22.4	0.77 (0.63 to 0.94)	0.83 (0.67 to 1.02)
≥85	21.0	0.71 (0.58 to 0.87)	0.82 (0.66 to 1.01)
Women	24.0	0.89 (0.75 to 1.06)	1.12 (0.94 to 1.34)
Cognitive function
No/mild impairment	26.4	Reference	Reference
Moderate impairment	21.0	0.74 (0.61 to 0.90)	0.79 (0.65 to 0.97)
Severe impairment	19.7	0.68 (0.55 to 0.84)	0.80 (0.64 to 0.99)
Diabetes	25.5	1.20 (1.02 to 1.43)	1.17 (0.98 to 1.39)
Anxiety	26.1	1.24 (1.04 to 1.48)	1.20 (1.00 to 1.44)
Presence of pain
No pain	16.0	Reference	Reference
Mild/infrequent	27.5	1.99 (1.61 to 2.45)	1.85 (1.49 to 2.29)
Moderate/severe	24.0	1.66 (1.31 to 2.10)	1.60 (1.26 to 2.03)

^*Reference group for the outcome included residents who did not have an increase in OMEs and added adjuvants.

^¶Odds ratios shown were adjusted for all resident characteristics displayed in the table.